Biomedical Engineering Reference
In-Depth Information
[10] J.P.K. Tan, A.Q.F. Zeng, C.C. Chang, K.C. Tam, Release kinetics of procaine hydrochloride from pH-
responsive nanogels: theory and experiments, Int. J. Pharm. 357 (2008) 305
313.
[11] A.A. Date, M.S. Nagarsenker, Parenteral microemulsions: an overview, Int. J. Pharm. 355 (2008)
19
30.
[12]
J.M. Lee, K.M. Park, S.J. Lim, M.K. Lee, C.K. Kim, Microemulsion formulation of clonixic acid: solu-
bility enhancement and pain reduction, J. Pharm. Pharmacol. 54 (2002) 43
49.
[13] L.M.A. Pinto, L.F. Fraceto, M.H.A. Santana, T.A. Pertinhez, S.O. Junior, E. de Paula, Physico-chemical
characterization of benzocaine-
β
-cyclodextrin inclusion complexes, J. Pharm. Biomed. Anal. 39 (2005)
956
963.
[14] M.D. Blanco, M.V. Bernardo, R.L. Sastre, R. Olmo, E. Muniz, J.M. Teij´n, Preparation of bupivacaine-
loaded poly(
ε
-caprolactone) microspheres by spray drying: drug release studies and biocompatibility,
Eur. J. Pharm. Biopharm. 55 (2003) 229
236.
[15] P.L. Corre, J.P. Est`be, R. Cl´ment, et al., Spray-dried bupivacaine-loaded microspheres: in vitro evalua-
tion and biopharmaceutics of bupivacaine following brachial plexus administration in sheep, Int.
J. Pharm. 238 (2002) 191
203.
[16] K. Tomoda, M. Asahiyama, E. Ohtsuki, T. Nakajima, H. Terada, M. Kanebako, et al., Preparation and
properties of carrageenan microspheres containing allopurinol and local anesthetic agents for the treat-
ment of oral mucositis, Colloids Surf. B 71 (2009) 27
35.
[17] M.V. Bernardo, M.D. Blanco, R. Olmo, J.M. Teij
´
n, Delivery of bupivacaine included in poly(acrylam-
ide-co-monomethyl itaconate) hydrogels as a function of the pH swelling medium, J. Appl. Polym. Sci.
86 (2002) 327
334.
[18] C.M. Moraes, R. de Lima, A.H. Rosa, E. de Paula, L.F. Fraceto, Encapsulation of local anesthetic bupi-
vacaine in biodegradable poly(DL-lactide-co-glycolide) nanospheres: factorial design, characterization
and cytotoxicity studies, Macromol. Symp. 281 (2009) 106
112.
[19] P.S. Madhu, S. Setty, S. Ravindra, Dentinal hypersensitivity?—Can this agent be the solution? Indian
J. Dent. Res. 17 (2006) 178
184.
[20] M. Addy, E.G. Absi, D. Adams, Dentin hypersensitivity. The effects in vitro of acids and dietary sub-
stances on root-planed and burred dentin, J. Clin. Periodontol. 14 (1987) 274
279.
[21] M. Br¨nnstr¨m, G. Johnson, Effects of various conditioners and cleaning agents on prepared dentin sur-
faces: a scanning electron microscopic investigation, J. Prosthet. Dent. 31 (1974) 422
430.
[22] R.H. Dababneh, A.T. Khouri, M. Addy, Dentin hypersensitivity—an enigma? A review of terminology,
mechanisms, aetiology and management, Br. Dent. J. 187 (1999) 606
611.
[23] R.A. Freitas Jr, Nano-dentistry, J. Am. Dent. Assoc. 131 (2000) 1559
1566.
[24] R.A. Freitas Jr, Micro biovores artificial mechanical phagocytes using digest and discharge protocol,
J. Evol. Technol. 14 (2005) 1
52.
[25] T.S.V. Satyanarayana, R. Rai, Nanotechnology: the future, J. Interdiscip. Dent. 1 (2) (2011) 93
100.
[26] A.V. Rybachuk,
I.S. Chekman, T.Y. Nebesna, Nanotechnology and nanoparticles
in dentistry,
Pharmacol. Pharm. 1 (2009) 18
21.
[27] K. Jayaraman, M. Kotaki, Y. Zhang, et al., Recent advances in polymer fibers, J. Nanosci. Nanotechnol.
4 (2004) 65
67.
[28] R.L. Price, K. Ellison, K.M. haberstroh, et al., Nanometer surface roughness increase select osteoblasts
adhesion on carbon nanofiber compacts, J. Biomed. Mater. 70 (2004) 38
40.
[29] M. Zamani, M. Morshed, J. Varshosaz, M. Jannesari, Controlled release of metronidazole benzoate from
poly epsilon-caprolactone electrospun nanofibers for periodontal diseases, Eur. J. Pharm. Biopharm. 75
(2010) 179
185.
[30] R. Krishnamurthy, M. Manning, The stability factor: importance in formulation development, Curr.
Pharm. Biotechnol. 3 (2002) 361
371.
